Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Internal Medicine, Nephrology, and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands; Institute of Experimental Medicine and Systems Biology, University Hospital RWTH Aachen, Aachen, Germany.
Trends Cell Biol. 2024 Apr;34(4):299-311. doi: 10.1016/j.tcb.2023.09.005. Epub 2023 Oct 19.
The rising prevalence of kidney diseases urges the need for novel therapies. Kidney organoids and tubuloids are advanced in vitro models and have recently been described as promising tools to study kidney (patho)physiology. Recent developments have shown their application in disease modeling, drug screening, and nephrotoxicity. These applications rely on their ability to mimic (dys)function in vitro including endocrine activity and drug, electrolyte, and water transport. This review provides an overview of these emerging kidney models and focuses on the most recent developments that utilize their functional capabilities. In addition, we cover current limitations and provide future perspectives for this rapidly evolving field, including what these functional properties mean for translational and personalized medicine now and in the future.
肾脏疾病的患病率不断上升,这促使我们需要开发新的治疗方法。肾脏类器官和肾小管类器官是先进的体外模型,最近被描述为研究肾脏(病理)生理学的有前途的工具。最近的研究表明,它们可应用于疾病建模、药物筛选和肾毒性研究。这些应用依赖于它们在体外模拟(功能)障碍的能力,包括内分泌活性以及药物、电解质和水的转运。本综述概述了这些新兴的肾脏模型,并重点介绍了利用其功能特性的最新进展。此外,我们还讨论了当前的局限性,并为这一快速发展的领域提供了未来的展望,包括这些功能特性对转化医学和个性化医学现在和未来的意义。